Pneumococcal conjugate second or third-dose vaccines (PCVc) in Democratic Republic of Congo
Democratic Republic of Congo: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 63.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Democratic Republic of Congo, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Democratic Republic of Congo is 63.0%, measured in 2025.
The figure is down 1.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Democratic Republic of Congo peaked at 72.0% in 2019 and was at its lowest, 0.0%, in 2008.
That places Democratic Republic of Congo 142nd out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Democratic Republic of Congo, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 3.0% | — |
| 2012 | 23.0% | +666.7% |
| 2013 | 34.0% | +47.8% |
| 2014 | 48.0% | +41.2% |
| 2015 | 64.0% | +33.3% |
| 2016 | 66.0% | +3.1% |
| 2017 | 69.0% | +4.5% |
| 2018 | 70.0% | +1.4% |
| 2019 | 72.0% | +2.9% |
| 2020 | 69.0% | -4.2% |
| 2021 | 63.0% | -8.7% |
| 2022 | 64.0% | +1.6% |
| 2023 | 59.0% | -7.8% |
| 2024 | 63.0% | +6.8% |
| 2025 | 63.0% | +0.0% |
Democratic Republic of Congo compared with similar countries
- Democratic Republic of Congo's 63.0% is below the median for low income countries, which is 80.0%, 79% of the median. (25 countries reporting)
- Democratic Republic of Congo's 63.0% is below the median for Sub-Saharan Africa, which is 82.5%, 76% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Democratic Republic of Congo changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +666.7% | 3.0% | 23.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 44.9% | 0.0% | 72.0% | 10 |
| 2020s | 63.5% | 59.0% | 69.0% | 6 |
Countries ranked near Democratic Republic of Congo
- 140 South Africa 65.0% compare
- 141 Benin 64.0% compare
- 142 Afghanistan 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Laos 62.0% compare
- 144 Nigeria 62.0% compare
More health data for Democratic Republic of Congo
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133,650 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 390 (2025)
- Population ages 00-04, female, annual growth rate 2.56 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0895 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Democratic Republic of Congo?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Democratic Republic of Congo was 63.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Democratic Republic of Congo?
- The highest recorded value was 72.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Democratic Republic of Congo?
- The lowest recorded value was 0.0% in 2008.
- How does Democratic Republic of Congo rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Democratic Republic of Congo ranks 142nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Democratic Republic of Congo?
- Over the last ten years it is down 1.6%. The long-run trend across the full record is volatile.
- Where does this Democratic Republic of Congo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).